Kaletra/Selzentry ( lopinavir/ritonavir/maraviroc) / Abbott - LARVOL DELTA

Five important takeaways from recent COVID-19 recommendations (Healio) - "IDSA guideline panelist Rajesh T. Gandhi, MD, said the evidence supporting other therapies like hydroxychloroquine alone or in combination with azithromycin; lopinavir/ritonavir; tocilizumab; and convalescent plasma is uncertain. These agents should be evaluated in clinical trials to 'find out what works and what does not,' he noted....'The worst of the pandemic may have passed before COVID-19 related clinical trial results are published and, even then, there is no guarantee that the clinical trials will be definitive. Sometimes you must act based upon indirect evidence and clinical observations until the trial results become available,' he said."

Media quote